Marktrücknahme bei Produkten der Pharmaindustrie aufgrund der Referenzpreissystematik

This written question seeks to clarify why pharmaceutical companies are withdrawing products from the market due to the reference pricing system. It addresses the impact of pricing regulations on the availability of medicines for patients. This procedure affects pharmaceutical manufacturers and patients who may lose access to specific medications if companies find them financially unviable to sell under current pricing rules.